Imbalance of regulatory T cells in human autoimmune diseases.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMC 1782226)

Published in Immunology on March 01, 2006

Authors

Christian Dejaco1, Christina Duftner, Beatrix Grubeck-Loebenstein, Michael Schirmer

Author Affiliations

1: Clinical Department of Internal Medicine, Innsbruck Medical University, Innsbruck, Austria.

Associated clinical trials:

T-regulatory Cells in ALS (Tregs in ALS) | NCT04055623

Articles citing this

IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest (2008) 4.12

Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest (2010) 2.00

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One (2009) 1.69

Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol (2009) 1.56

B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol (2010) 1.39

Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer (2007) 1.26

Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology (2007) 1.22

Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem (2010) 1.17

CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells. Immunology (2007) 1.13

Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12

Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11

Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology (2010) 1.10

Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol (2007) 1.08

Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? Immunol Lett (2007) 1.05

Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J Clin Immunol (2009) 1.05

IPEX and the role of Foxp3 in the development and function of human Tregs. J Clin Invest (2006) 1.04

Treg functional stability and its responsiveness to the microenvironment. Immunol Rev (2014) 1.01

Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol (2007) 0.99

Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice. J Immunol (2011) 0.99

Innate immune system and preeclampsia. Front Immunol (2014) 0.98

Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis. PLoS One (2013) 0.97

Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest Ophthalmol Vis Sci (2011) 0.96

Selected Aspects in the Pathogenesis of Autoimmune Diseases. Mediators Inflamm (2015) 0.95

Is multiple sclerosis an autoimmune disease? Autoimmune Dis (2012) 0.94

Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients. Haematologica (2012) 0.94

The impact of aging on regulatory T-cells. Front Immunol (2013) 0.89

Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC. PLoS One (2014) 0.88

CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer (2011) 0.87

Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol (2014) 0.87

Aging of the CD4 T Cell Compartment. Open Longev Sci (2012) 0.87

Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem (2010) 0.87

Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int (2009) 0.86

Regulatory T cells and Atherosclerosis. J Clin Exp Cardiolog (2012) 0.85

Immunoregulatory T cells, LFA-3 and HLA-DR in autoimmune thyroid diseases. Indian J Endocrinol Metab (2014) 0.81

Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases. Mediterr J Hematol Infect Dis (2012) 0.81

Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS One (2014) 0.80

The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers (2015) 0.80

Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to Hypoxia. Am J Physiol Cell Physiol (2015) 0.80

Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. Mediators Inflamm (2012) 0.80

Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunol Cell Biol (2015) 0.79

Th17 and Treg cells in bone related diseases. Clin Dev Immunol (2013) 0.79

Trichostatin A promotes the generation and suppressive functions of regulatory T cells. Clin Dev Immunol (2013) 0.79

Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response. Clin Exp Immunol (2007) 0.79

Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Sci Rep (2015) 0.78

Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications. Am J Cancer Res (2015) 0.78

PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood (2017) 0.78

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation. Sci Rep (2016) 0.77

Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity. Rambam Maimonides Med J (2015) 0.77

Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Immunology (2014) 0.77

The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian J Pharmacol (2012) 0.76

[A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation]. Wien Med Wochenschr (2009) 0.76

Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity. Front Immunol (2015) 0.76

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R(+) T cells. Cardiovasc Diabetol (2016) 0.75

Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol (2017) 0.75

The role of lymphocytes in the development and treatment of alopecia areata. Expert Rev Clin Immunol (2015) 0.75

Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iran J Basic Med Sci (2015) 0.75

Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy. Mediators Inflamm (2016) 0.75

Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension. Can J Physiol Pharmacol (2016) 0.75

Artesunate influences Th17/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis. Exp Ther Med (2017) 0.75

Articles cited by this

(truncated to the top 100)

Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05

Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity (2005) 23.00

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol (2004) 17.40

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 15.44

Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol (2005) 13.03

CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol (2002) 12.73

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26

CD4+CD25high regulatory cells in human peripheral blood. J Immunol (2001) 11.25

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med (1999) 10.67

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med (2004) 8.98

Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med (2002) 8.84

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86

Origin of regulatory T cells with known specificity for antigen. Nat Immunol (2002) 7.49

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol (2005) 6.77

Natural regulatory T cells in infectious disease. Nat Immunol (2005) 6.49

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med (2004) 6.48

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest (2003) 6.42

Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology (1970) 6.06

Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A (2005) 5.96

Maintaining the norm: T-cell homeostasis. Nat Rev Immunol (2002) 5.63

Mechanisms of suppression by suppressor T cells. Nat Immunol (2005) 5.52

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol (2005) 5.43

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity (2002) 5.38

Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med (2004) 5.08

Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol (2002) 4.95

Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol (2004) 4.59

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med (2004) 4.35

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes (2005) 4.34

Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity (2004) 4.11

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest (2005) 3.83

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol (2004) 3.79

Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol (2005) 3.65

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet (2002) 3.61

Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med (1998) 3.59

HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol (2004) 3.43

CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum (2004) 3.36

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev (2001) 3.31

Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med (2005) 3.29

Type 1 T regulatory cells. Immunol Rev (2001) 3.26

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol (2004) 3.18

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology (2004) 3.18

Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol (2003) 3.16

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol (2004) 3.15

T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A (2003) 2.94

Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun (2003) 2.81

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood (2004) 2.76

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med (2004) 2.73

A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest (2005) 2.71

CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum (2003) 2.68

Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin Immunol (2005) 2.60

De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci U S A (2005) 2.57

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood (2005) 2.55

Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant (2004) 2.55

Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol (2002) 2.51

CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol (2004) 2.45

Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med (2004) 2.43

Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 2.33

CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther (2004) 2.25

CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol (2003) 2.19

CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun (2005) 1.96

Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol (2004) 1.92

The regulatory T cell family: distinct subsets and their interrelations. J Immunol (2003) 1.92

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A (2005) 1.90

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood (2004) 1.90

CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol (2004) 1.89

Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol (2003) 1.80

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med (2005) 1.79

CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (2005) 1.76

Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol (2005) 1.76

Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol (2003) 1.76

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J Clin Invest (2004) 1.74

Regulatory/suppressor T cells in health and disease. Arthritis Rheum (2004) 1.65

Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65

Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors. Proc Natl Acad Sci U S A (2001) 1.61

A causal link between lymphopenia and autoimmunity. Immunol Lett (2004) 1.61

The B7/CD28 costimulatory family in autoimmunity. Immunol Rev (2005) 1.57

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54

T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci U S A (1999) 1.54

Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res (2003) 1.53

Regulatory T cells and autoimmune disease. Immunol Rev (2005) 1.51

Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression. Eur J Immunol (2004) 1.46

Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol (2004) 1.43

Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest (2004) 1.41

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood (2003) 1.41

QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet (1999) 1.39

T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol (2004) 1.38

Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol (2004) 1.38

CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr (2004) 1.38

CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells. J Immunol (2005) 1.36

How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol (1998) 1.29

Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol (2003) 1.29

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun (2005) 1.28

Articles by these authors

Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 5.00

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47

Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res (2003) 3.44

Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol (2002) 3.22

Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol (2005) 2.84

Human immunosenescence: is it infectious? Immunol Rev (2005) 2.83

Is immunosenescence infectious? Trends Immunol (2004) 2.47

Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol (2007) 2.33

Biology of immune responses to vaccines in elderly persons. Clin Infect Dis (2008) 2.32

The aging of the immune system. Transpl Int (2009) 2.32

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell (2010) 2.31

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25

Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest (2009) 1.81

Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.71

High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (2005) 1.65

Vaccination in the elderly: an immunological perspective. Trends Immunol (2009) 1.60

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell (2004) 1.51

Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol (2008) 1.49

Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire. J Clin Immunol (2011) 1.48

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS (2011) 1.47

Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology (2005) 1.47

[Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations?]. Wien Klin Wochenschr (2002) 1.46

Challenges for vaccination in the elderly. Immun Ageing (2007) 1.42

Age-associated changes within CD4+ T cells. Immunol Lett (2006) 1.38

Remitting seronegative syndrome with pitting edema as the presenting symptom in a young, male patient with sarcoidosis: a case report. Arthritis Rheum (2008) 1.38

The value of contrast-enhanced color Doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis. Arthritis Rheum (2002) 1.38

How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell (2015) 1.34

Major vessel involvement in Behçet's disease: an update. Curr Opin Rheumatol (2011) 1.31

Persistent viral infections and immune aging. Ageing Res Rev (2010) 1.31

Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells. J Immunol (2011) 1.29

Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine (2005) 1.28

Major vessel involvement in Behçet disease. Curr Opin Rheumatol (2005) 1.27

Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res (2001) 1.26

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther (2006) 1.24

Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med (2007) 1.24

Are regulatory T-cells linked with aging? Exp Gerontol (2006) 1.22

Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing (2010) 1.22

Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. J Rheumatol (2002) 1.21

Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol (2012) 1.20

CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 1.17

Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol (2005) 1.17

Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol (2006) 1.17

The impact of aging on memory T cell phenotype and function in the human bone marrow. J Leukoc Biol (2011) 1.16

CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol (2005) 1.16

Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule. Nat Immunol (2011) 1.15

Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell (2012) 1.15

IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J Immunol (2003) 1.12

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis. Arthritis Res Ther (2003) 1.11

The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol (2008) 1.09

Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell (2010) 1.09

Naive T cells in the elderly: are they still there? Ann N Y Acad Sci (2006) 1.07

Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life. Clin Immunol (2008) 1.07

Value of contrast-enhanced ultrasound in rheumatoid arthritis. Eur J Radiol (2007) 1.05

T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol (2007) 1.05

Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells. Int Immunol (2005) 1.04

What are the effects of maternal and pre-adult environments on ageing in humans, and are there lessons from animal models? Mech Ageing Dev (2005) 1.02

Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis (2010) 1.01

A Darwinian-evolutionary concept of age-related diseases. Exp Gerontol (2003) 1.01

Microarray analysis reveals similarity between CD8+CD28- T cells from young and elderly persons, but not of CD8+CD28+ T cells. Biogerontology (2008) 1.00

Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol (2005) 1.00

The gracefully aging immune system. Sci Transl Med (2013) 0.99

Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine (2006) 0.99

Inflammatory low back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints. Arthritis Rheum (2005) 0.98

Electrons as "invisible ink": fabrication of nanostructures by local electron beam induced activation of SiOx. Angew Chem Int Ed Engl (2010) 0.98

Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis Res Ther (2005) 0.97

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years. Vaccine (2010) 0.95

Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS One (2012) 0.94

Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients. Arthritis Rheum (2008) 0.93

Techniques in gerontology: cell lines as standards for telomere length and telomerase activity assessment. Exp Gerontol (2006) 0.93

Fusion of real-time US with CT images to guide sacroiliac joint injection in vitro and in vivo. Radiology (2010) 0.93

Ageing and immunity: addressing immune senescence to ensure healthy ageing. Vaccine (2010) 0.92

An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr (2009) 0.92

The effect of chronological age on the inflammatory response of human fibroblasts. Exp Gerontol (2012) 0.92

Ultrasonography in inflammatory rheumatic disease: an overview. Nat Rev Rheumatol (2011) 0.92

[Vaccination against Alzheimer disease?]. Wien Klin Wochenschr (2003) 0.91

Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003. J Rheumatol (2004) 0.91

Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging (2003) 0.91

Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings. Arthritis Rheum (2005) 0.90

CD28(-)CD8(+) T cells do not contain unique clonotypes and are therefore dispensable. Immunol Lett (2009) 0.89

Electron-beam-induced deposition in ultrahigh vacuum: lithographic fabrication of clean iron nanostructures. Small (2008) 0.89

Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. Vaccine (2011) 0.89

The impact of aging on regulatory T-cells. Front Immunol (2013) 0.89

Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study. Am Heart J (2006) 0.89

The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age. Transpl Immunol (2011) 0.88

Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding. J Gerontol A Biol Sci Med Sci (2010) 0.87

Generation of clean iron structures by electron-beam-induced deposition and selective catalytic decomposition of iron pentacarbonyl on Rh(110). Langmuir (2009) 0.87

Coalition of advocates to vaccinate of Western European citizens aged 60 years and older. Aging Clin Exp Res (2009) 0.87

The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis. Wien Med Wochenschr (2005) 0.86

Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int (2009) 0.86